Dietary Nitrate and Muscle Power With Aging
Primary Purpose
Aging, Sarcopenia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
placebo
nitrate
Sponsored by
About this trial
This is an interventional treatment trial for Aging focused on measuring nitric oxide
Eligibility Criteria
Inclusion Criteria:
In good health, as determined by the investigator's review of history (provided by subject at screening visit), physical examination, and routine blood and urine tests (done at screening visit)
Exclusion Criteria:
Men and women <65 or >79 years of age
- Unable to provide informed consent
- Currently pregnant or lactating (given the age range for the study, verbal confirmation by subject is believed to be sufficient)
- Current smokers
- Significant orthopedic limitations or other contraindications to strenuous exercise
- Those taking phosphodiesterase inhibitors (e.g., Viagra)
- Those taking proton pump inhibitors, antacids, xanthine oxidase inhibitors, or on hormone replacement therapy
- Those taking anti-coagulants (e.g., Coumadin) or on anti-platelet therapy
- History of neuromuscular disease (e.g., cervical spondylotic radiculomyelpathy, lumbar spondylosis, amyotrophic lateral sclerosis, Guillain-Barré syndrome, and acquired demyelinating polyneuropathies), cardiovascular disease (e.g., > stage I hypertension, heart failure, myocardial infarction/ischemia, significant myocardial or pericardial diseases (e.g. amyloidosis, constriction), moderate or severe valvular disease, renal disease, liver disease, or anemia
Sites / Locations
- Indiana University School of Health and Human Sciences
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
placebo
nitrate
Arm Description
Outcomes
Primary Outcome Measures
Muscle function
Maximal knee extensor speed and power determined using isokinetic dynamometry
Muscle function
Maximal knee extensor speed and power determined using isokinetic dynamometry
Secondary Outcome Measures
Muscle cGMP
Muscle cyclic guanosine monophosphate concentration
Muscle cGMP
Muscle cyclic guanosine monophosphate concentration
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03513302
Brief Title
Dietary Nitrate and Muscle Power With Aging
Official Title
Dietary Nitrate and Muscle Power With Aging
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
March 1, 2019 (Actual)
Primary Completion Date
August 30, 2022 (Actual)
Study Completion Date
August 30, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indiana University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to see if drinking beetroot juice (BRJ) is beneficial for aging patients. We hope to determine the effect of BRJ on exercise performance. BRJ improves exercise performance in athletes and normal people. We are trying to determine if BRJ improves exercise performance in aging patients. We will be comparing the effects of BRJ versus the effects of a placebo (BRJ without the nitrates that are naturally occurring in beets and other similar foods). It is thought that the benefits of BRJ may come from its natural nitrate content. Although BRJ is available for purchase in grocery stores, for the purposes of this study it is considered investigational, which means that it has not been approved as a medical therapy.
Detailed Description
This study consists of two parts separated by a 14 day wash-out. Subjects will be randomly assigned to receive either the BRJ or placebo during the first part. During the second part they will receive the opposite of what they had during the first part. This is considered a double-blind study, which means neither the subjects nor the investigators will know what form (BRJ or placebo) a subject is receives.
Study Visit One (Screening) 1-2 hours
The purpose of the screening visit is to explain all aspects of the study. It will also determine if subjects can participate in the study. Subjects will provide a complete medical history and undergo a physical exam. They will have their blood drawn (about 1.5 teaspoons) and provide a urine sample. They will also practice the entire neuromuscular function exercise test. During this test, the strength of their muscles will be determined by having them kick, push and/or pull back as hard as you can while their leg is strapped to an exercise device. A vital signs monitor will measure your blood pressure, heart rate, and rhythm.
During the remainder of the study subjects will be instructed to consume their normal diet. However, they will be asked to avoid eating foods high in nitrate such as beets, spinach, and collard greens the evening before each visit. They will be asked to refrain from the use of antibacterial mouthwash, such as Listerine or Cepacol, during the study. Chewing gum, alcohol, and food and drinks containing caffeine (coffee, tea, chocolate, and soft drinks) should be avoided 24 hours prior to each visit. They will be asked to fast for 12 hour prior to each study visit.
Study Visit Two - Approximately 5 hours
At the beginning of this visit a catheter (small, flexible, sterile plastic tube) will be placed through a vein in one of the subject's arms. This is for collection of blood samples. Blood will be drawn four times during this visit. Each draw will be 6 mL or about 1.2 teaspoons. The first blood draw will check nitrate and nitrite levels. They will then have a breath test to check nitric oxide. They will then drink 140 mL (about 2/3 of a cup) of BRJ (or placebo). Blood and breath samples will be obtained every hour. Heart rate and blood pressure will be measured at the same times the blood and breath samples are obtained. Subjects will then rest quietly in a private room for about 2 hours after ingestion of BRJ (or placebo) then will perform:
The neuromuscular function test that was practiced during the screening visit.
After completing the exercise test they will undergo a muscle biopsy of their thigh muscle. First, the area will be sterilized and numbed with an injection. Next, a small incision (about ¼ inch) will be made and a small biopsy needle will be used to collect a small sample of your muscle (about the size of a pencil eraser). This will be performed on the leg opposite of that used during the neuromuscular test.
One final blood and breath sample will then be obtained.
Subjects will then be provided a 7 day supply of BRJ (or placebo) and will continue to drink two bottles (about 5 oz) every morning.
Subjects will also be provided with an activity tracker. This will be worn at the hip during all waking hours except when bathing or swimming. This monitor will measure total activity time and sedentary time.
Study Visit Three - 1-2 hours
Subjects will return to the research center with the empty BRJ bottles. At this visit a single blood (1.2 teaspoon) and breath sample will be collected. Subjects will then complete a questionnaire to rate how tired they felt during the previous week. They will be provided another 7 day supply of BRJ (or placebo) and will continue to drink two bottles every morning.
Study Visit Four - Approximately 5 hours Subjects will return to the research center and undergo the same procedures as they did in Study Visit Two. They will also complete a questionnaire that will rate how tired they felt during the previous week.
Washout After visit four subjects will undergo a 14 day washout period where they will not drink the BRJ (or placebo). There are no dietary restrictions at this time; subjects may consume caffeine, alcohol, gum, mouthwash, etc. Subjects will then repeat Study Visits Two, Three, and Four again. However, during this they will be given the opposite form of BRJ you had received before.
Study Visit Five Subjects will repeat the procedures completed during Study Visit Two.
Study Visit Six Subjects will repeat the procedures completed during Study Visit Three.
Study Visit Seven Subjects will repeat the procedures completed during Study Visit Four.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aging, Sarcopenia
Keywords
nitric oxide
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Double-blind, placebo-controlled, crossover
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Title
nitrate
Arm Type
Active Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Other Intervention Name(s)
Beet It Sport Nitrate 400 placebo
Intervention Description
2 x 70 mL concentrated beet root juice depleted of nitrate per day for 14 days.
Intervention Type
Dietary Supplement
Intervention Name(s)
nitrate
Other Intervention Name(s)
Beet It Sport Nitrate 400
Intervention Description
2 x 70 mL concentrated beet root juice per day for 14 days.
Primary Outcome Measure Information:
Title
Muscle function
Description
Maximal knee extensor speed and power determined using isokinetic dynamometry
Time Frame
1 day
Title
Muscle function
Description
Maximal knee extensor speed and power determined using isokinetic dynamometry
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Muscle cGMP
Description
Muscle cyclic guanosine monophosphate concentration
Time Frame
1 day
Title
Muscle cGMP
Description
Muscle cyclic guanosine monophosphate concentration
Time Frame
14 days
Other Pre-specified Outcome Measures:
Title
Plasma nitrate
Description
Plasma nitrate concentrations
Time Frame
0,1,2,3 hours after treatment at 1 and 14 days
Title
Plasma nitrite
Description
Plasma nitrite concentrations
Time Frame
0,1,2,3 hours after treatment at 1 and 14 days
Title
Breath nitric oxide
Description
Breath nitric oxide level
Time Frame
0,1,2,3 hours after treatment at 1 and 14 days
Title
Perceived fatigue
Description
Perceived fatigue questionnaire (PROMIS 8a)
Time Frame
1,7,14 days of treatment
Title
Physical function
Description
Physical function questionnaire (PROMIS 20a)
Time Frame
1,7,14 days of treatment
Title
Physical activity
Description
Physical activity (total and bouted) from ActiGraph monitors
Time Frame
1,7,14 days of treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
In good health, as determined by the investigator's review of history (provided by subject at screening visit), physical examination, and routine blood and urine tests (done at screening visit)
Exclusion Criteria:
Men and women <65 or >79 years of age
Unable to provide informed consent
Currently pregnant or lactating (given the age range for the study, verbal confirmation by subject is believed to be sufficient)
Current smokers
Significant orthopedic limitations or other contraindications to strenuous exercise
Those taking phosphodiesterase inhibitors (e.g., Viagra)
Those taking proton pump inhibitors, antacids, xanthine oxidase inhibitors, or on hormone replacement therapy
Those taking anti-coagulants (e.g., Coumadin) or on anti-platelet therapy
History of neuromuscular disease (e.g., cervical spondylotic radiculomyelpathy, lumbar spondylosis, amyotrophic lateral sclerosis, Guillain-Barré syndrome, and acquired demyelinating polyneuropathies), cardiovascular disease (e.g., > stage I hypertension, heart failure, myocardial infarction/ischemia, significant myocardial or pericardial diseases (e.g. amyloidosis, constriction), moderate or severe valvular disease, renal disease, liver disease, or anemia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew Coggan, PhD
Organizational Affiliation
Indiana University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Indiana University School of Health and Human Sciences
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29547495
Citation
Coggan AR. Dietary Nitrate and Muscle Function in Humans: Acute versus Chronic Mechanisms. Med Sci Sports Exerc. 2018 Apr;50(4):874. doi: 10.1249/MSS.0000000000001489. No abstract available.
Results Reference
background
PubMed Identifier
29368802
Citation
Coggan AR, Broadstreet SR, Mikhalkova D, Bole I, Leibowitz JL, Kadkhodayan A, Park S, Thomas DP, Thies D, Peterson LR. Dietary nitrate-induced increases in human muscle power: high versus low responders. Physiol Rep. 2018 Jan;6(2):e13575. doi: 10.14814/phy2.13575.
Results Reference
background
PubMed Identifier
28916479
Citation
Coggan AR, Broadstreet SR, Mahmood K, Mikhalkova D, Madigan M, Bole I, Park S, Leibowitz JL, Kadkhodayan A, Thomas DP, Thies D, Peterson LR. Dietary Nitrate Increases VO2peak and Performance but Does Not Alter Ventilation or Efficiency in Patients With Heart Failure With Reduced Ejection Fraction. J Card Fail. 2018 Feb;24(2):65-73. doi: 10.1016/j.cardfail.2017.09.004. Epub 2017 Sep 12.
Results Reference
background
PubMed Identifier
27271563
Citation
Coggan AR, Peterson LR. Dietary Nitrate and Skeletal Muscle Contractile Function in Heart Failure. Curr Heart Fail Rep. 2016 Aug;13(4):158-65. doi: 10.1007/s11897-016-0293-9.
Results Reference
background
PubMed Identifier
26641379
Citation
Rimer EG, Peterson LR, Coggan AR, Martin JC. Increase in Maximal Cycling Power With Acute Dietary Nitrate Supplementation. Int J Sports Physiol Perform. 2016 Sep;11(6):715-720. doi: 10.1123/ijspp.2015-0533. Epub 2016 Aug 24.
Results Reference
background
PubMed Identifier
26179185
Citation
Coggan AR, Leibowitz JL, Spearie CA, Kadkhodayan A, Thomas DP, Ramamurthy S, Mahmood K, Park S, Waller S, Farmer M, Peterson LR. Acute Dietary Nitrate Intake Improves Muscle Contractile Function in Patients With Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Trial. Circ Heart Fail. 2015 Sep;8(5):914-20. doi: 10.1161/CIRCHEARTFAILURE.115.002141. Epub 2015 Jul 15.
Results Reference
background
PubMed Identifier
25199856
Citation
Coggan AR, Leibowitz JL, Kadkhodayan A, Thomas DP, Ramamurthy S, Spearie CA, Waller S, Farmer M, Peterson LR. Effect of acute dietary nitrate intake on maximal knee extensor speed and power in healthy men and women. Nitric Oxide. 2015 Aug 1;48:16-21. doi: 10.1016/j.niox.2014.08.014. Epub 2014 Sep 6.
Results Reference
background
Learn more about this trial
Dietary Nitrate and Muscle Power With Aging
We'll reach out to this number within 24 hrs